Abbott Laboratories (NYSE:ABT) – Abbott’s Earnings Increase 22% Year Over Year, But Is It A Buy?

[at Seeking Alpha] – Abbott Laboratories ( ABT ) is engaged in the discovery, development, manufacture and sale of a portfolio of science-based healthcare products, which operates in four segments: Diagnostics, Medical Devices, . . . → Read More: Abbott Laboratories (NYSE:ABT) – Abbott’s Earnings Increase 22% Year Over Year, But Is It A Buy? Similar Articles: Duke Energy Corp (NYSE:DUK) | Duke Energy to announce fourth quarter and year-end 2013 earnings on Feb. 18 Abbott Laboratories (NYSE:ABT) | ModernGraham Valuation Of Abbott Laboratories Company Update – Abbott Laboratories (NYSE:ABT) – Abbott Laboratories Raised Its Dividend 57%, But Is It A Buy Right Now?